货号:GS40592
Recaticimab is a fully human monoclonal antibody designed to target and inhibit proprotein convertase subtilisin/kexin type 9 (PCSK9). By binding to PCSK9, it prevents PCSK9-mediated degradation of low-density lipoprotein receptors (LDLR) on liver cells, thereby increasing LDL cholesterol clearance from the bloodstream. It is developed for the treatment of hypercholesterolemia and cardiovascular risk reduction.
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
冉凯凯